Files | Discussion Wiki | Discussion | Discussion

default Loading...



Loading wiki pages...

Wiki Version:
<h2>Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors</h2> <p><br> <strong>Abstract:</strong></p> <p>In 2015, as part of the <a href="" rel="nofollow">Reproducibility Project: Cancer Biology</a>, we published a Registered Report (<a href="" rel="nofollow">Chroscinski et al., 2015</a>), that described how we intended to replicate selected experiments from the paper “The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors“ (<a href="" rel="nofollow">Willingham et al., 2012</a>). Here we report the results of those experiments. We found that treatment of immune competent mice bearing orthotopic breast tumors with anti-mouse CD47 antibodies resulted in short-term anemia compared to controls, consistent with the previously described function of CD47 in normal phagocytosis of aging red blood cells and results reported in the original study (Table S4; <a href="" rel="nofollow">Willingham et al., 2012</a>). The weight of tumors after 30 days administration of anti-CD47 antibodies or IgG isotype control were not found to be statistically different, whereas the original study reported inhibition of tumor growth with anti-CD47 treatment (Figure 6A,B; <a href="" rel="nofollow">Willingham et al., 2012</a>). Additionally, the excised tumors were scored for inflammatory cell infiltrates. Both IgG and anti-CD47 treated tumors resulted in minimal to moderate lymphocytic infiltrate, while neutrophilic infiltration was slightly increased in anti-CD47 treated tumors, while the original study observed sparse lymphocytic infiltrate in IgG-treated tumors and increased inflammatory cell infiltrates in anti-CD47 treated tumors (Figure 6C; <a href="" rel="nofollow">Willingham et al., 2012</a>). Finally, we report a meta-analysis of the result.</p> <hr> <h3>Contents</h3> <p><strong>Reports:</strong> Read the <a href="" rel="nofollow">Replication Study</a>, or view the <a href="" rel="nofollow">preprint versions</a>. </p> <p>To reproduce the Replication Study manuscript text run this in <a href="" rel="nofollow">R Studio</a> (note: downloads <a href="" rel="nofollow">R markdown file</a> directly from <a href="" rel="nofollow"></a>):</p> <pre class="highlight"><code>library(httr) library(rmarkdown) GET(&quot;<a href="" rel="nofollow"></a>&quot;, write_disk(&quot;Replication_Study_39.Rmd&quot;, overwrite = T)) render(&quot;Replication_Study_39.Rmd&quot;, output_format = &quot;word_document&quot;)</code></pre> <p><br> Also, explore the <a href="" rel="nofollow">Registered Report</a> and materials related to the Registered Report <a href="" rel="nofollow">here</a>.</p> <p><br> <strong>Experiments replicated:</strong> Reproduce and explore the figures, analyses, data, and methods generated in this replication attempt.</p> <ul> <li><a href="" rel="nofollow">Engraftment of mouse breast cancer cells and treatment with CD47 targeted antibodies</a></li> <li>Replication of Figures 6A-C and Table S4 in Willingham et al., 2012.</li> </ul> <p><br> <strong>Meta-analyses:</strong> As a measure of evaluating reproducibility a meta-analysis of each effect was performed. The forest plots, analyses, and data are available <a href="" rel="nofollow">here</a>.</p> <p><br> Questions about the project can be directed to <a href=""></a>.</p>
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.

Create an Account Learn More Hide this message